Literature DB >> 21551870

Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome.

R Duvdevani1, M Rosner, M Belkin, J Sautter, B A Sabel, M Schwartz.   

Abstract

In the present study, we have developed an animal model for central nervous system (CNS) damage using the graded crush injury of the adult rat optic nerve. This injury model has the following characteristics: (a) the injuries are reproducible; (b) the injuries can be created with controlled severity; and (c) variations in the severity of the injuries correlate with definable electrophysiological and behavioral outcomes. Self-closing forceps, modified by attaching a screw to the handle, were used as a lesion-causing device. Rat optic nerves were crushed in vitro. The severity of the injury, calibrated by a measured applied force, was determined, electrophysiologically, in vitro. Compound action potential was assessed and recorded by suction electrodes connected to both sides of the nerve. In vivo studies correlated the calibrated crush injuries with behavioral outcome. After severe crush (applied force: 205 g or higher), the rats were unable to orient towards visual stimuli presented in the visual field of the damaged nerve and only minor transient recovery was observed. After moderate crush (applied force: 120 g), however, there was a significant recovery of orienting performance up to the 6th postoperative day, followed by a gradual, secondary loss of function. In the mildly injured group (applied force lower than 30 g), functional improvement continued for up to 10 days and remained stable thereafter, with only minor secondary loss. This CNS graded injury model may be valuable to study the molecular and anatomical mechanisms underlying secondary degeneration and the potency of various posttraumatic treatments in leading to recovery of function.

Entities:  

Year:  1990        PMID: 21551870     DOI: 10.3233/RNN-1990-2104

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  8 in total

1.  Quantification of histological changes after calibrated crush of the intraorbital optic nerve in rats.

Authors:  Nils-Claudius Gellrich; Ronald Schimming; Martin Zerfowski; Ulf Theodor Eysel
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

Review 2.  Evidence for the existence of low-energy laser bioeffects on the nervous system.

Authors:  M Belkin; M Schwartz
Journal:  Neurosurg Rev       Date:  1994       Impact factor: 3.042

3.  T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies.

Authors:  J Kipnis; E Yoles; Z Porat; A Cohen; F Mor; M Sela; I R Cohen; M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

4.  A behavioral model of excitotoxicity: retinal degeneration, loss of vision, and subsequent recovery after intraocular NMDA administration in adult rats.

Authors:  B A Sabel; J Sautter; T Stoehr; R Siliprandi
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

5.  Rodent model of nonarteritic ischemic optic neuropathy and its electrophysiological evaluation.

Authors:  Hideki Chuman; Tomoyuki Maekubo; Takako Osako; Yu Kodama; Michitaka Ishiai; Nobuhisa Nao-I
Journal:  Jpn J Ophthalmol       Date:  2012-08-03       Impact factor: 2.447

6.  Cholinergic Potentiation of Restoration of Visual Function after Optic Nerve Damage in Rats.

Authors:  Mira Chamoun; Elena G Sergeeva; Petra Henrich-Noack; Shaobo Jia; Lisa Grigartzik; Jing Ma; Qing You; Frédéric Huppé-Gourgues; Bernhard A Sabel; Elvire Vaucher
Journal:  Neural Plast       Date:  2017-08-27       Impact factor: 3.599

7.  Ovariectomy worsens visual function after mild optic nerve crush in rodents.

Authors:  Rachael S Allen; Amber Douglass; Harrison Vo; Andrew J Feola
Journal:  Exp Eye Res       Date:  2020-10-28       Impact factor: 3.467

Review 8.  Proregenerative properties of ECM molecules.

Authors:  Stefan Plantman
Journal:  Biomed Res Int       Date:  2013-09-09       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.